methaqualone

(redirected from Somnomed)
Also found in: Dictionary, Thesaurus.

methaqualone

 [meth″ah-qua´lōn]
a nonbarbiturate compound formerly used as a sedative and hypnotic; now found only as a drug of abuse. See drug abuse.

methaqualone

(mĕth′ə-kwā′lōn′)
n.
A potentially habit-forming drug, C16H14N2O, formerly used as a sedative and hypnotic.

methaqualone

An addictive Schedule-II hypnotic-sedative quinazolone with barbiturate-like effects which, when it was legal, was used to reduce anxiety and tension. It was a popular drug of abuse, and it was linked to physical or psychologic dependence.

Clinical findings
Delirium, headache, nausea, pyramidal signs, convulsions, renal and cardiac failure; rarely, aplastic anaemia.
 
Route
Oral, injected, sniffed, smoked.
 
Management of overdose
Haemoperfusion.

Toxic range
> 8 µg/mL, serum; > 300 µg/L, urine.
 
T1/2
20–60 hours.
 
Specimen
Serum, random urine.
 
Method
GC.

methaqualone

Quaalude, 'ludes' Substance abuse An addictive Schedule II hypnotic-sedative quinazolone with barbiturate-like effects; methaqualone was a popular drug of abuse and linked to physical or psychologic dependence Clinical Delirium, headache, nausea, pyramidal signs, convulsions, renal and cardiac failure; rarely, aplastic anemia Route Oral, injected, sniffed, smoked Used for Anxiety, tension Management Hemoperfusion. See Controlled drug substance.

methaqualone

a nonbarbiturate hypnotic similar to barbiturates in its effects.
References in periodicals archive ?
SomnoMed provides sleep apnea, snoring and bruxism.
SomnoMed has entered into an agreement with TP Korea Orthodontics Lab Co Ltd ("TP"), the leading orthodontic laboratory in Korea, whereby TP will take responsibility for logistics and customer services.